Computational modeling and experimental validation of nitrile-thiol reactivity in Janus kinase inhibitors

Authors: Kim, Elaine; Lee, Zheng-Chi; Wang, Leo L

Source journal: RSC medicinal chemistry (2026-11-09)

DOI: 10.1039/d6md00709k

Abstract

Despite their therapeutic potential and FDA approval for various autoimmune diseases, oral Janus kinase (JAK) inhibitors have been limited by systemic toxicities. We previously identified a reaction between the nitrile group of baricitinib, a JAK1/2 inhibitor, and cysteamine-modified hyaluronic acid, which forms a hydrogel that sustains release after injection. To evaluate thiol reactivity across nitrile-containing JAK inhibitors, we applied established B3LYP-based density functional theory (DFT) protocols to predict activation barriers for three FDA-approved JAK inhibitors in the presence of cysteamine. Theoretical activation energies (DeltaG (double dagger)) were compared with experimental rate constants to assess agreement between computational and experimental reactivity. Truncating the molecules to the local chemical environment surrounding the nitrile moiety improved this correlation for the three inhibitors studied. Our findings identify directions for future methodological refinement of B3LYP-based DFT modeling of aliphatic nitrile reactivity in JAK inhibitors. These results may inform further studies of nitrile-thiol conjugation for controlled drug delivery.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.